Rigontec: Rigontec GmbH Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 24092018 Prices from USD $250

SummaryRigontec GmbH Rigontec is a biopharmaceutical company that carries out the development of RNAbased immunotherapeutics for the treatment of viral diseases and cancer. The company designs synthetic ligands of a novel receptor of the innate immune syst...